KRAS and cancer: The transcription of YAP1 and TAZ in the Hippo signaling pathway plays a critical role in mediating the resistance of major cancer treatment drugs, and is considered to play a major driving role in the development of resistance of BRAF- and KRAS- mutant cancer cells (12, 25, 26).